Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Castells

Showing results (301-310 of 353) with videos related to

Pageof 36
Sort By:
Lancet (London, England)|March 30, 2025
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trialAntoni Castells, Enrique Quintero, Luis Bujanda, et al.
British Journal of Pharmacology|July 8, 2025
Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancerAna Rita Simoes, Silvia Carlés González, María Del Carmen Lopez-Doldan, et al.
Carcinogenesis|November 20, 2012
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populationsCeres Fernandez-Rozadilla, Claire Palles, Luis Carvajal-Carmona, et al.
Carcinogenesis|May 29, 2016
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)Rosa M Xicola, Sneha Bontu, Brian J Doyle, et al.
Plos One|April 19, 2014
The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individualsAnna Abulí, Luis Bujanda, Jenifer Muñoz, et al.
Gut|August 27, 2011
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancerLucía Pérez-Carbonell, Clara Ruiz-Ponte, Carla Guarinos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Clinical subtypes and molecular characteristics of serrated polyposis syndromeCarla Guarinos, Cristina Sánchez-Fortún, María Rodríguez-Soler, et al.
JAMA|October 18, 2012
Identification of Lynch syndrome among patients with colorectal cancerLeticia Moreira, Francesc Balaguer, Noralane Lindor, et al.
International Journal of Cancer|May 30, 2025
Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndromeXavier Domínguez-Rovira, Coral Arnau-Collell, Gemma Gonfaus-Ortiz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2022
Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer ScreeningCoral Arnau-Collell, Anna Díez-Villanueva, Beatriz Bellosillo, et al.
Pageof 36

Showing results (301-310 of 353) with videos related to

Sort By:
Pageof 36
Lancet (London, England)|March 30, 2025
Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trialAntoni Castells, Enrique Quintero, Luis Bujanda, et al.
British Journal of Pharmacology|July 8, 2025
Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancerAna Rita Simoes, Silvia Carlés González, María Del Carmen Lopez-Doldan, et al.
Carcinogenesis|November 20, 2012
BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populationsCeres Fernandez-Rozadilla, Claire Palles, Luis Carvajal-Carmona, et al.
Carcinogenesis|May 29, 2016
Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC)Rosa M Xicola, Sneha Bontu, Brian J Doyle, et al.
Plos One|April 19, 2014
The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individualsAnna Abulí, Luis Bujanda, Jenifer Muñoz, et al.
Gut|August 27, 2011
Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancerLucía Pérez-Carbonell, Clara Ruiz-Ponte, Carla Guarinos, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2013
Clinical subtypes and molecular characteristics of serrated polyposis syndromeCarla Guarinos, Cristina Sánchez-Fortún, María Rodríguez-Soler, et al.
JAMA|October 18, 2012
Identification of Lynch syndrome among patients with colorectal cancerLeticia Moreira, Francesc Balaguer, Noralane Lindor, et al.
International Journal of Cancer|May 30, 2025
Germline pathogenic variants in HIC1 DNA binding domains are associated with familial serrated polyposis syndromeXavier Domínguez-Rovira, Coral Arnau-Collell, Gemma Gonfaus-Ortiz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 5, 2022
Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer ScreeningCoral Arnau-Collell, Anna Díez-Villanueva, Beatriz Bellosillo, et al.
Pageof 36